Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), the primary hepatic malignancy, represents the second-highest cause of cancer-related death worldwide. Many efforts have been devoted to finding novel biomarkers for predicting both patients’ survival and the outcome of pharmacological treatments, with a particular fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabbia, Daniela, De Martin, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960420/
https://www.ncbi.nlm.nih.gov/pubmed/36834851
http://dx.doi.org/10.3390/ijms24043441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960420/
https://www.ncbi.nlm.nih.gov/pubmed/36834851
http://dx.doi.org/10.3390/ijms24043441

Ejemplares similares